Published in Physician Law Weekly, February 23rd, 2005
If proved successful in further clinical studies, the procedure could become the first tool for early diagnosis of Alzheimer, and the first test to conclusively identify the disease in living patients.
Chad Mirkin and William Klein of the National Science Foundation (NSF) Nanoscale Science and Engineering Center (NSEC) for Nanopatterning and Detection Technologies at Northwestern University, and their colleagues, announced their findings the week of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly
Source: Physician Law Weekly (2005-02-23)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.